Medical Equipment

Hemostats And Tissue Sealants Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Hemostats And Tissue Sealants Market During The Forecast Period 2026–2030?

The hemostats and tissue sealants market has experienced significant expansion in recent years. Its valuation is predicted to increase from $4.35 billion in 2025 to $4.64 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. The growth observed in the past can be ascribed to factors like the reliance on traditional mechanical hemostats, the limited availability of synthetic sealants, an increase in surgical procedures, the expansion of hospital infrastructure, and the early adoption of fibrin-based sealants.

The hemostats and tissue sealants market is projected to experience substantial expansion over the coming years. This market is set to reach a value of $5.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this growth during the forecast period include advancements in next-generation tissue adhesives, an increase in minimally invasive surgeries, a rise in cardiovascular and trauma surgeries, intensified research in hemostasis technologies, and the broadening of direct and online distribution channels. Key trends anticipated during this period encompass the growing acceptance of advanced hemostatic products, greater utilization of synthetic and combination sealants, an increase in cardiovascular and trauma surgeries, an emphasis on minimally invasive procedures for quicker recovery, and expanding research and academic applications within hemostasis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25781&type=smp

Which Economic Or Industry Drivers Are Impacting The Hemostats And Tissue Sealants Market?

An increasing volume of surgical operations is projected to advance the expansion of the hemostats and tissue sealants market in the upcoming period. Surgical procedures are defined as medical interventions that involve manual and instrumental techniques utilized by surgeons to diagnose, treat, or remove diseased tissues or organs, or to repair bodily functions. The uptick in surgical procedures is attributable to the rising prevalence of chronic diseases, which frequently demand surgical intervention for their effective management, treatment, or prevention of complications. Hemostats and tissue sealants facilitate surgical procedures by efficiently managing bleeding and sealing tissues, thereby minimizing complications and elevating surgical outcomes. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional body for board-certified aesthetic plastic surgeons, there was a 5.5% rise in surgical procedures in 2023, with more than 15.8 million surgeries and 19.1 million non-surgical procedures performed globally. Thus, the growing number of surgical procedures is fostering the development of the hemostats and tissue sealants market.

What Market Segments Are Evaluated Within The Hemostats And Tissue Sealants Market?

The hemostats and tissue sealants market covered in this report is segmented –

1) By Product Type: Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types

2) By Composition: Biological Based, Synthetic Based, Combination

3) By Distribution Channel: Direct Sales, Distributors, Online Sales

4) By Application: Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications

5) By End-Users: Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes

Subsegments:

1) By Topical Hemostats: Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats

2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives

3) By Fibrin Sealants: Liquid Fibrin Sealants, Patch-Based Fibrin Sealants

4) By Other Product Types: Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

What Industry Trends Are Redefining The Hemostats And Tissue Sealants Market?

Major companies active in the hemostat and tissue sealants market are concentrating on developing advanced products, such as ready-to-use absorbable collagen pads hemostat, to boost efficiency and improve outcomes in surgical care. Ready-to-use absorbable collagen pads of hemostat incorporate bioactive, resorbable materials that allow for immediate application without preparation, facilitating quick and effective tissue and dura sealing as well as hemostasis. For instance, in April 2025, Baxter International Inc., a US-based healthcare company, unveiled Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. This new room temperature Hemopatch sealing hemostat offers ready-to-use convenience without the need for pre-warming, enabling rapid application during surgery. It is an innovative absorbable pad that can be applied directly during both open and minimally invasive surgeries, removing the need for product preparation or refrigeration. The product’s strong adhesive properties, extended shelf life, and rapid hemostatic effect assist surgeons in managing bleeding or leakage more efficiently, ultimately supporting enhanced surgical precision and patient recovery across various specialties.

Who Are The Top Market Participants Influencing The Hemostats And Tissue Sealants Market?

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

Read the full hemostats and tissue sealants market report here:

https://www.thebusinessresearchcompany.com/report/hemostats-and-tissue-sealants-global-market-report

What Are The Top-Performing Regions Within The Hemostats And Tissue Sealants Market?

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hemostats And Tissue Sealants Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25781&type=smp

Browse Through More Reports Similar to the Global Hemostats And Tissue Sealants Market 2026, By The Business Research Company

Absorbable Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/absorbable-hemostats-global-market-report

Hemostasis Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795